In­sil­i­co Med­i­cine and Tai­wan-based CD­MO Bo­ra Phar­ma­ceu­ti­cals are launch­ing a new com­pa­ny with an AI-dri­ven bi­o­log­ics man­u­fac­tur­ing plat­form in a bid to com­pete with ser­vice...

John­son & John­son is an­tic­i­pat­ing as much as $750 mil­lion in costs to re­struc­ture its phar­ma­ceu­ti­cal sup­ply chain and ex­it fac­to­ries, moves that are com­ing...

The num­ber of drugs in short­age in the US rose for a third straight quar­ter, a sit­u­a­tion com­pli­cat­ed by the fact that al­most half of...

The FDA on Fri­day post­ed 14 new re­jec­tion let­ters to phar­ma com­pa­nies on­line, days af­ter HHS con­firmed to End­points Newsthat the agency had paused...

Ad­van­Cell raised a $315 mil­lion Se­ries D to study a lead-based prostate can­cer agent and shore up its US man­u­fac­tur­ing of the ra­dioac­tive treat­ment.

The...

The FDA is propos­ing a rule to change how fac­to­ries are reg­is­tered with the agency if they are mak­ing prod­ucts for the US mar­ket, as...

Ger­many’s fed­er­al par­lia­ment has vot­ed to pass a bill de­signed to cut do­mes­tic health­care spend­ing that could neg­a­tive­ly im­pact drug­mak­ers, draw­ing sharp crit­i­cism from the...